logo

Kinnate Biopharma Inc. (KNTE)



Trade KNTE now with
  Date
  Headline
9/14/2022 4:39:27 PM Wedbush Reiterates Kinnate Biopharma Inc. (KNTE) At Outperform With $33 Price Target
3/29/2022 10:42:38 AM Wedbush Is Increasing Kinnate Biopharma Inc. (KNTE) FY 22 Estimate To -2.22 From -2.69
3/29/2022 10:42:17 AM Wedbush Is Increasing Kinnate Biopharma Inc. (KNTE) Q4 22 Estimate To -0.60 From -0.81
3/29/2022 10:42:01 AM Wedbush Is Increasing Kinnate Biopharma Inc. (KNTE) Q3 22 Estimate To -0.53 From -0.72
3/29/2022 10:41:21 AM Wedbush Is Increasing Kinnate Biopharma Inc. (KNTE) Q2 22 Estimate To -0.47 From -0.60
3/29/2022 10:41:06 AM Wedbush Is Cutting Kinnate Biopharma Inc. (KNTE) Q1 22 Estimate To -0.65 From -0.55
3/29/2022 10:39:55 AM Wedbush Reiterates Kinnate Biopharma Inc. (KNTE) At Outperform With $39 Down From $44 Price Target